By proceeding, you agree to our Terms of Use and Privacy Policy.
Kypha discovers, develops and commercializes innovative in-vitro diagnostic biomarker tests within the inflammation and autoimmune space.
27-29 September 2022
With promising clinical data, an increasing number of candidates progressing through the clinic and a rise in diseases where complement drugs are being applied, it's time to accelerate transformative complement-targeted approaches towards approval! A
Event Ended
USA
Paid
Boston
11-13 September 2023
The field of complement-based drug development is experiencing growth due to several factors. Firstly, there is an increasing recognition of the role of the complement system in a wider range of diseases. Additionally, there is a better understanding